Synthesis of Heterocyclic Compounds with Antitumor Properties
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (1 July 2023) | Viewed by 337
Special Issue Editors
Interests: voltage- and ligand-gated ion channels (particularly, TRP and Kv channels); nutraceuticals, medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer represents the second leading cause of death worldwide. To date, drug treatment together with surgical operation, radiotherapy, and chemotherapy constitute the main approaches to cancer treatment. Small molecules with heterocyclic scaffold are widely used to treat a variety of cancers with small molecules and show great diversity in their action mechanisms. Over the past two decades, there has been a huge shift in cancer treatment, leading to targeted drugs; nevertheless, this significant progress in treatment is still not very specific or effective. Therefore, we are currently facing numerous difficulties relating to the search for progress in cancer chemotherapy. This Special Issue aims to gather relevant and innovative research advances in the field of development of new anticancer compound and drug development. We invite all researchers working in this field to contribute original articles which present the results of their research activity. Both original research articles and reviews are welcome for submission.
Prof. Dr. Pietro Campiglia
Dr. Veronica Di Sarno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- cancer prevention
- antitumor activity
- chemotherapy
- pharmacological properties
- in vitro and in vivo studies
- tumor cells selectivity
- structural activity relationship (SAR)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
